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Since mesenchymal stem cell (MSC)-based therapies have shown therapeutic potentials for the repair of myocardial infarctions and prevention of post-infarct congestive heart failure, [1] [2] [3] many attempts have been made to enhance the beneficial effects of MSCs via modifications before transplantation, including pretreatment with growth factors and cytokines, preconditioning, and genetic modification. [4] [5] [6] [7] [8] These approaches have yielded enhanced beneficial effects of MSCs in infarcted myocardium, however, most of the studies have focused on modifying the cellular properties of the transplanted MSCs and not the damaged cardiomyocytes directly. Periostin, a secreted extracellular matrix molecule of the fasciclin family, participates in cell adhesion, migration, and growth. 9 It can serve as a ligand for several integrins, such as αvβ3 and αvβ5. 10, 11 In the heart, periostin is expressed at very early stages of embryogenesis; however, it is not detected in the normal adult myocardium, except in the valves and in some types of heart disease. 12, 13 In general, periostin is upregulated in adult tissues under adverse conditions such as damage, overload, and/or stress. [14] [15] [16] Indeed, recent studies have shown that periostin is upregulated several-fold in the infarct border of human and mouse heart with acute myocardial infarction (AMI). [17] [18] Wang et al. (2000) reported a 40-fold increase in periostin mRNA in mouse hearts when subjected to pressure overload. In addition, the fact that periostin is associated with other critical extracellular matrix (ECM) regulators such as transforming growth factor-β (TGF-β), tenascin, and fibronectin, and that it is a critical regulator of fibrosis via alteration of the deposition and attachment of collagen 19 indicate that periostin could be a factor involved in myocardial fibrosis after infarction. Oka et al. (2007) also provided important data showing that periostin can modify adhesion between myocytes and fibroblasts, possibly modifying wall stiffness or biomechanical properties, depending on whether periostin's expression is increased or downregulated. Moreover, it has been reported that periostin, delivered through the cardiac extracellular matrix, can increase cardiomyocyte proliferation, an event which requires integrins such as, αvβ3, αvβ5, and α4β4, and the phosphatidylinositol-3-OH kinase (PI3K) pathway.
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Although there are no studies liking periostin directly to myocardial cell death or loss, the regulation of periostin expression could have clinical implications that affect myocardial remodeling directly or possibly indirectly through altered hemodynamics. The aim of this study was to reveal the role of periostin in cardiac protection and healing of the infarcted myocardium using the implantation of periostin-overexpressing MSCs. We hypothesized that periostin would protect cardiomyocytes from apoptosis induced by ischemic stress through integrin-mediated enhancement of survival signal, PI3K. In addition, periostin may facilitate the survival of engrafted MSCs themselves and promote adhesion to infarcted hearts, leading to increased capacity for cardiac regeneration.
II. MATERIALS AND METHODS

Isolation and culture of MSCs
Mesenchymal stem cells were isolated from the femoral and tibial bones of rats. Briefly, bone marrow from femoral and tibial bones of four-week-old male Sprague-Dawley rats (approximately 100 g) was aspirated with 10 ml of Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and 1% antibiotic-penicillin/streptomycin solution. Mononuclear cells recovered after centrifugation in Percoll were washed twice, resuspended in 10% fetal bovine serum (FBS)-DMEM, and plated in flasks at 1 x 10 6 cells per 100 cm 2 . Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . After 48 or 72 hrs, non-adherent cells were discarded, and adherent cells were thoroughly washed twice with phosphate-buffered saline (PBS). Fresh complete medium was added and replaced every 3 to 4 days for approximately 10 days. For further purification, the Isolex Magnetic Cell Selection System (Baxter Healthcare Corporation, Irvine, CA, http://www.baxter.com) was used. Briefly, cells were incubated with Dynabeads M-450 coated with anti-CD34 monoclonal antibody. A magnetic field was applied and CD34+ cell-bead complexes were separated from the remaining cell suspension; the CD34-negative fraction was then cultured. Cells were harvested after incubation with 0.25% trypsin and 1 mM EDTA for 5 min at 37°C, replated in 1 x 10 5 /100-cm 2 plates, and grown for approximately 10 days.
LentiV-mediated stable genetic modification of MSCs
For stable genetic modification, we used a lentiviral vector (LentiV) for transgene delivery. The LentiV harboring the periostin gene with a mCMV promoter and the green fluorescent protein (GFP) gene with a pgk promoter was constructed by inserting the gene fragments into the EcoR1-Bam HI site of the LentiV (SeouLin Bioscience Co. Ltd., Seoul, Korea, http://www.seoulin.co.kr). The periostin (361945 postn) cDNA clone was purchased from B2BIO (B2BIO Co., Seoul, Korea, http://www.b2bio.co.kr) and the cDNA was amplified using the following primer set: Forward: 5'-gaattcgccaccatggttcctctcctgccctta-3', Reverse: 5'-ggatccctgagaacggccttctcttga-3'. MSCs were transduced by adding purified LentiVs to the cells in the presence of 6 μg/ml of polybrene to facilitate transduction.
3. Annexin V/PI staining Apoptosis was measured using an ApoScan™ Annexin V/FITC apoptosis detection kit (Biobud, Seoul, Korea). Cells were pelleted and analyzed in the FACSCalibur system. The excitation frequency was 488 nm. The green fluorescence emitted by Annexin V (FL1) and the red fluorescence of PI (FL2) were measured using 525 nm and 575 nm bandpass filters, respectively. A total of at least 1×10 4 cells were analyzed in each sample. Light scattering was measured on a linear scale using 1,024 channels and the fluorescence intensity was assessed on a logarithmic scale. ) were harvested in lysis buffer (1 M DTT) and the cell extracts were centrifuged to eliminate cellular debris. Cell extract aliquots of 50 µl were incubated at 37°C for 2 hours in the presence of the chromophore substrate. Free DEVD-pNA was then determined colorimetrically. By comparing the absorbance of pNA from apoptotic samples with uninduced controls, we could determine the fold increase in capase-3 activity. Data denote means ± S.E.M. of 2 to 3 replicate measurements in three different cell cultures.
5. Cell proliferation assay Cellular proliferation was measured with the PreMix WST-1 Cell Proliferation Assay System (TAKARA BIO Inc., Shiga, Japan, http://www.takara-bio.com). This system enables the measurement of cell proliferation with a colorimetric assay that is based on the cleavage of slightly red tetrazolium salt (WST-1) by mitochondrial succinate-tetrazolium reductase in viable cells. An increase in enzyme activity leads to an increase in the production of formazan dye, thus the quantity of formazan dye is related directly to the number of metabolically active cells in the medium. 2 × 10 4 cells were seeded into wells of a 96-well culture plate and incubated under hypoxic conditions after transduction of the lentiviral vector. The WST-1 cell proliferation reagent was added directly to the supernatant (10 µl/100 µl growth medium) and incubated at 37°C for 3 hours. We then determined the absorbance of the solubilized dark red formazan product at 450 nm.
6. Confocal microscopy and fluorescence measurements Cytosolic free Ca 2+ concentrations were estimated by confocal microscopy.
Neonatal rat cardiomyocytes were plated in a four well slide chamber coated with 7. Induction of myocardial infarction and transplantation All experimental procedures for animal studies were approved by the Committee for the Care and Use of Laboratory Animals, Yonsei University College of Medicine, and performed in accordance with the Committee's Guidelines and Regulations for Animal Care. Myocardial infarction was produced in male Sprague-Dawley rats (200 ± 30 g) by surgical occlusion of the left anterior descending coronary artery. Briefly, after induction of anesthesia with ketamine (10 mg/kg) and xylazine (5 mg/kg), the third and fourth ribs were cut to open the chest, and the heart was exteriorized through the intercostal space. The left coronary artery was ligated 2-3 mm from its origin with a 5-0 prolene suture (ETHICON, Somerville, NJ, http://www.ethicon.com) for 3 days. For transplantation, cells were suspended in 10 μl of serum-free medium (1 × 10 6 cells) and injected into tissues from the injured region to the border using a Hamilton syringe (Hamilton Co., Reno, NV, http://www.hamiltoncompany.com) with a 30-gauge needle. Throughout the operation, animals were ventilated with 95% O 2 and 5% CO 2 using a Harvard ventilator. The operative mortality was 10% within 48 hrs. Six animals per group (ligation, MSCs, p-MSCs) were used for morphologic analysis after occlusion of the left coronary artery.
Immunohistochemistry
Histological analysis was performed according to the instructions of the manufacturer (R.T.U VECTASTAIN Universal Quick Kit, Vector Laboratories, Burlingame, CA, http://www.vectorlab.com). In brief, the excised heart tissues were fixed in 3.7% buffered formaldehyde and embedded in paraffin. Tissue sections, 5 µm thick, were deparaffinized, rehydrated, and rinsed with PBS. Sodium citrate antigen retrieval was experimented with 10 mM sodium citrate (pH6.0) in a microwave for 10 minutes. Sections were incubated in 3% H 2 O 2 in order to quench endogenous peroxidase. Sample was blocked in 2.5% normal horse serum, and incubated in primary antibody. Biotinylated pan-specific universal secondary antibody and streptavidin/peroxidase complex reagent were used to treat the heart section. Using a DAB substrate kit, the heart section was stained with antibody. Counterstain was used in 1% methyl green and dehydration was performed with 100% N-butanol, ethanol, and xylene.
9. Immunoblot analysis Cells were washed once in PBS and lysed in lysis buffer (Cell Signaling Technology, Beverly, MA, http://www. cellsignal.com) containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM Na 2 -EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride. Protein concentrations were determined using the Bradford Protein Assay Kit (Bio-Rad, Hercules, CA, http://www.bio-rad.com). Proteins were separated in a 12% sodium dodecyl sulfate-polyacrylamide gel and transferred to a polyvinylidene difluoride membrane (Millipore, Billerica, MA, http://www.millipore.com). After blocking the membrane with Tris-buffered saline-Tween 20 (TBS-T, 0.1% Tween 20) and 5% nonfat dried milk for 1 hour at room temperature, the membrane was washed twice with TBS-T and incubated with primary antibody for 1 hour at room temperature or overnight at 4°C. Next, the membrane was washed three times with TBS-T for 10 minutes and incubated for 1 hour at room temperature with horseradish peroxidase-conjugated secondary antibodies. After extensive washing, the bands were detected with an enhanced chemiluminescence reagent (Santa Cruz Biotechnology, Santa Cruz, CA, http://www.scbt.com). The band intensities were quantified using a Photo-Image System (Molecular Dynamics, Sunnyvale, CA, http://www.mdyn.com).
RT-PCR analysis
Total RNA was extracted using 500 μL/60 mm-diameter plate of TRIzol (Sigma). Chloroform (100 μL) was added to the extract and each sample was vortexed for about 10 sec. Next, centrifugation at 12,000 g, at 4°C for 15 min, caused three layers to appear, and the transparent upper layer was collected in a new tube. Each sample next received 250 μL 2-propanol, and vortexing for about 30 sec was repeated. Centrifugation at 12,000 g, at 4°C for 10 min, followed. The supernatant was discarded and the pellet washed in 75% (v/v) ethanol admixed with diethylpyrocarbonate (DEPC; Sigma), and dissolved in water. Centrifugation at about 7,500 g, at 4°C for 5 min, followed. The supernatant was again discarded and the pellet dried at room temperature for about 7 min. Finally, each pellet was dissolved in 30 μL nuclease-free water (NFW). The quality and quantity of RNA were estimated by calculation of OD260/OD280 ratios using a DU 640 spectrophotometer (Eppendorf, Hamburg, Germany). Complementary DNA (cDNA) was synthesized using the RT&GO™ kit. One microgram of RNA was added to 1 μL of the anchored primer dT 25V, 2 μL dithiothreitol (DTT), and NFW, to yield a final volume of 9 μL. To prevent development of secondary structure, the mixture was incubated for 5 min at 70°C and 8 μL RT-&GO™ mastermix was next added. Each sample was incubated at 42°C for 1 hour. Next, reverse transcriptase was added and incubation continued at 70°C for 15 min. As described above after isolation of total RNA, sample quality and quantity were estimated by calculation of OD260/OD280 ratios. One microgram of cDNA, and 10 pmol of each primer (forward and backward; Table 1), 0.1 mM of a dNTP mixture, 1.25 U Taq polymerase, and 10 X reaction buffer were mixed with NFW to give a final volume of 25 μL. PCR conditions were as follows. A cycle of denaturation at 94°C for 3 min was followed by 35 elongation cycles each featuring denaturation at 94°C for 30 sec, annealing at 48-60°C for 30 sec, and elongation at 72°C for 30 sec. The reaction was next held at 72°C for 10 min. Primers used are shown in Table 1 . PCR products were separated by electrophoresis in 1.2% (w/v) agarose gels (BioRad, Seoul, Korea) and Gel-Doc (BioRad) was used to visualize bands after staining with ethidium bromide (Sigma).
Left ventricular catheterization
For invasive hemodynamics, left ventricular catheterization was performed at 7 days after operation. A Millar Micro-tip 2 F pressure transducer (model SPR-838, Millar Instruments, Houston, TX) was introduced into the left ventricle via the right carotid artery under zoletil (20 mg/kg) and xylazine (5 mg/kg) anesthesia. Real time pressure-volume loops were recorded by a blinded investigator and all data were analyzed with PVAN 3.5 software (Millar).
12. Determination of infarct size TTC staining was used to assess myocardial tissue viability and determine the size of the myocardial infarct. The tissue slices were incubated in a 1% 2, 3, 5-triphenyltetrazolium chloride (TTC, Sigma, St. Louis, MO, http://www. sigma.com) solution, pH 7.4, at 37°C for 20 minutes. The tissues were fixed in 10% PBS-buffered formalin overnight at 2-8°C. The hearts were sectioned transaxially and the size of the MI was evaluated as a percentage of the sectional area of the infarcted tissue of the left ventricle to the sectional area of the whole left ventricle. Both sides of each TTC-stained tissue slice were photographed with a digital camera.
13. Histology and determination of the Area of fibrosis At several intervals after implantation, the transplants were killed and their hearts were excised. Each heart was perfusion-fixed with 10% (vol/vol) neutral-buffered formaldehyde for 24 hours, transversely sectioned into four comparably thick sections, and embedded in paraffin by routine methods. Sections of 2-μm thickness were mounted on gelatin-coated glass slides to ensure that different stains could be used on successive tissue sections cut through the implantation area. After deparaffinization and rehydration, the sections were stained with hematoxylin and eosin to assess cytologic details such as nuclei, cytoplasm, and connective tissue. Additionally, fibrosis was analyzed by Masson's Trichrome staining. The interstitial fibrosis areas were measured from control (n=6), MI (n=6), MI+MSCs (n=6), MI+Periostin-MSCs (n=6) groups using MetaMorph software version 4.6 (Universal Imaging Corp., Downtown, PA, http://www.universal-imaging.com), and expressed as a percentage of the total left ventricle.
14. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay The TUNEL Assay was performed according to the manufacturer's instructions (Chemicon International Inc. Temecula, CA, http://www.millipore.com). In brief, excised heart tissues were fixed in 3.7% buffered formaldehyde and embedded in paraffin. Tissue sections, 5 µm thick, were deparaffinized, rehydrated, and rinsed with PBS. A positive control sample was prepared from a normal heart section by treating the section with DNase I (10 U/ml, 10 minutes at room temperature). The sections were pretreated with 3.0% H2O2, subjected to TdT enzyme at 37°C for 1 hour, and incubated with digoxigenin-conjugated nucleotide substrate at 37°C for 30 minutes. Nuclei exhibiting DNA fragmentation were visualized by adding 3,3-diamino benzidine (DAB) (Vector Laboratories, Burlingame, CA, http://www.vectorlab.com) for 5 minutes. The nuclei of apoptotic cardiomyocytes were stained dark brown. Lastly, sections were counterstained with methyl green. A coverslip was placed on top of each section and the sections were observed by light microscopy. For each group, six slices were prepared and 10 different regions were observed in each slice (× 400) 15 . Statistical Analysis Data are expressed as means ± SE. Statistical comparisons between the two groups were performed using the Student´s t-test. In addition, a one-way ANOVA using a Bonferroni test was used when comparing more than two groups. A p-value <0.05 was considered significant.
III. RESULTS
Transduction of periostin into MSCs improves cell survival under hypoxic conditions
MSCs were isolated from mixed culture with hematopoietic cells based on their attachment to the culture plate, and further purified by exclusion with magnetic beads targeting the hematopoietic marker CD34. Yield was 3 x 10 6 cells (95% purity) after 2 wks of culture. Consistent with our previous reports [4, 8, 21] , the cultured MSCs expressed CD71, CD90, CD105, CD106, and intercellular adhesion molecule (ICAM), but not the hematopoietic markers CD34 and CD14. To investigate how periostin expression is altered by apoptotic stimuli, we determined the expression of periostin in MSCs under hypoxic conditions. We found that the expression of periostin was increased for up to 9 hrs under hypoxia, but decreased after 12 hrs and was eventually strongly downregulated (Fig. 1A) , which coincided with our observation that the survival rate of MSCs began to decrease after 9 hrs under hypoxic conditions and was eventually 60% lower than that of MSCs under normoxic conditions at 24 hrs (Fig. 1B) . These data suggest that alteration of the periostin level might be associated with the substantial cell death of MSCs following prolonged hypoxia. To determine whether periostin is a key factor regulating apoptotic death of MSCs under hypoxic conditions, we directly introduced GFP-tagged periostin into the MSCs using a lentiviral system. Using fluorescence microscopy, we observed that over ~50% of MSCs expressed GFP with no significant cytotoxicity (Fig. 1C) . We found that protein and mRNA expression levels were upregulated in p-MSCs by ~4 fold and ~6 fold, respectively, compared to levels in MSC controls (Fig. 1D) . In addition, the extracellular deposition of periostin was significantly increased in p-MSCs by ~3 fold compared to MSC control (Fig. 1E) . We used p-MSCs with greater than 95% of cells expressing GFP, collected by FACS, for further studies. We found that the survival rate of p-MSCs was increased by ~25% under hypoxia compared to MSC control (Fig. 1F) . Coincidently, the increased activity of caspase-3, which is known to be associated with cardiomyocyte death induced by hypoxia [21, 22] , was significantly reduced in p-MSCs under hypoxia (Fig.  1G ). In addition, the decreased expression of anti-apoptotic protein Bcl-2 was significantly and the expression of pro-apoptotic protein Bax was inhibited in p-MSCs under hypoxia (Fig. 1H) . Figure 1I shows a representative analysis and regional percentage of Annexin V vs. propridium iodide (PI) dot plot of MSCs transduced with or without periostin under hypoxia or normoxia. The transduction of periostin significantly decreased the percentage of damaged, necrotic, and apoptotic cells in the R1, R2, and R4 areas, respectively, compared to the untransduced MSC control under hypoxia. These results demonstrate that overexpression of periostin effectively enhances the viability of MSCs themselves. 
Co-culture with p-MSCs protects against cardiomyocyte death under hypoxia
To evaluate the effects of p-MSCs on rat cardiomyocytes under hypoxic conditions, we determined the survival rate of cardiomyocytes co-cultured with MSCs or p-MSCs. After exposure to hypoxia for 24 hrs, the viability of cardiomyocytes decreased by ~50% compared to control cells under normoxia. Although a cytoprotective effect was observed in the presence of both MSCs and p-MSCs, a greater degree of protection conferred by the p-MSCs was ~30% higher compared to cardiomyocytes co-cultured with MSCs ( Fig. 2A) , which coincided with the results from FACS analysis using Annexin V vs. PI dot plot (Fig. 2B ). In addition, we observed that the decreased expression levels of focal adhesion-related integrins, αv and β1 in hypoxic cardiomyocytes were significantly reversed when co-cultured with p-MSCs (Fig. 2C) . We further observed that caspase-3 activity, increased by ~60% under hypoxia, was reduced significantly in cardiomyocytes co-cultured with p-MSCs after 12 hrs of hypoxic exposure (Fig. 2D ), but showed no significant difference in cardiomyocytes co-cultured with MSC control. Significantly increased levels of phosphorylated ERK and Akt were also observed in p-MSC co-cultivation (Fig.  2E) . Furthermore, double-immunostaining showed that periostin and integrin were co-localized at the site of filopodia growth in the cardiomyocytes co-cultured with p-MSCs (Fig. 2F) . This co-localization suggests that periostin is involved in integrin-mediated cell survival in cardiomyocytes. Our results clearly indicate that periostin enhances the survival of cardiomyocytes through the activation of integrin-related survival signal pathways. 
Conditioned media from p-MSCs protects against hypoxia-induced cardiomyocyte death
To further investigate whether the cytoprotective effects of p-MSC on cardiomyocytes was due to periostin itself, not from the MSCs, we evaluated the effects of conditioned media (CM) from MSCs or p-MSCs on cardiomyocyte death under hypoxia. First, we observed that the level of secreted periostin in the media was significantly increased in media from p-MSCs compared to MSCs (data not shown). Similarly with co-culture experiments, the treatment with CM from p-MSCs significantly protected cardiomyocytes from death under hypoxia to a greater extent than did media from MSCs, which resulted in cell rescue equal to normal levels (Fig. 3A) . In addition, we obtained coincident results from FACS analysis using Annexin V vs. PI dot plot indicating that CM from p-MSCs significantly decreased Annexin V-positive cells by 60%, while CM from MSCs decreased Annexin V-positive cells by 40% (Fig. 3B) . These findings indicate that periostin may be a supporting factor to enhance cardiomyocyte survival under hypoxia and MSCs themselves might also secrete some factors that enhance cardiomyocyte survival. In addition, we observed that the decreased expression levels of the focal adhesion-related integrins, αv and β1 in hypoxic cardiomyocytes were significantly rescued when cells were grown in CM from p-MSC-treated cardiomyocytes (Fig. 3C) . We observed that the caspase-3 activity, increased by ~60% under hypoxia, was reduced significantly in CM from p-MSC-treated cardiomyocytes after 12 hrs of hypoxic exposure (Fig. 3D) . Significantly increased levels of phosphorylated ERK and Akt were also observed in CM from p-MSC-treated cardiomyocytes (Fig.  3E) . Furthermore, double-immunostaining showed that periostin and integrin were co-localized at the site of filopodia growth in CM from p-MSC-treated cardiomyocytes (Fig.  3F) . 
Implantation of p-MSCs significantly improves cardiac histopathology and functions in infarcted myocardium
To investigate the in vivo therapeutic efficacy of p-MSCs in infarcted myocardium, we transplanted p-MSCs or GFP-MSCs into the border region between the infarcted and normal areas of rat hearts after coronary ligation. As shown in Figure 4A , the engrafted cells were observed with green fluorescence. We found that implantation of p-MSCs significantly decreased infarct size by ~70% compared to sham-transplant controls and MSCs only with greater extent (Fig. 4B) . Even though the fibrosis area was significantly reduced in MSC-implanted groups, the degree of change was substantially higher than in the p-MSC-implanted groups (Fig. 4C) . The incidence of TUNEL-positive myocardial cells was also significantly reduced in the p-MSC-implanted groups compared to sham and MSC controls (Fig. 4D) . The mean microvessel count per field in the infarcted myocardium was significantly higher in the p-MSC group than in other groups (Fig. 4E) . To determine whether periostin is associated with integrin-mediated signal pathways in the myocardium, we examined activation and localization of integrin-related focal adhesion molecules such as, p-FAK, Src, and Talin using immunohistochemistry. As shown in Figure 4A , we could observe the specific staining of p-FAK, Src, and Talin on cardiomyocytes around engrafted GFP-positive p-MSCs, indicating that periostin carried by MSCs activates the formation of focal adhesion complexes in damaged cardiomyocytes, then protects against cardiomyocyte death. In addition, we observed that the phosphorylation of survival-related PI3K and Akt were significantly increased in the p-MSC-engrafted region of the infarcted myocardium (Fig. 4F) . To further examine the functional improvements fostered by p-MSC implantation, cardiac functions were evaluated by catheterization 21 days after injury and transplantation and compared to those of MSC-engrafted hearts. At baseline (i.e., after infarction and before cell implantation), left ventricular pressure volume analysis parameters were not significantly different between the control groups. Pressure-volume loop analyses showed less left ventricular dilation in the p-MSCs engrafted group compared to the MSC-engrafted group. The p-MSC-implanted group showed significant improvement of EDV, ESV, end-diastolic and end-systolic pressures, maximum rate of pressure rise (dP/dt max), and preload adjusted maximal power (Fig. 4G and Table 1 ). Transplantation of p-MSCs resulted in a better catheterization-determined ejection fraction and a steeper slope of the end-systolic pressure-volume relationship (ESPVR), suggesting cardiac regeneration through the p-MSC engraftment (Fig. 4D) . Table 1 . Effect of Periostin MSC on cardiac function in myocardial infarction. Change in the left ventricular pressure volume loops was obtained after a week of myocardial infarction and cell transplantation in rats, which showed differences in the HR, MAP, maximal LV pressure, LV end-diastolic pressure, ejection fraction, maximum pressure development, minimum pressure development, end-diastolic volume, end-systolic volume, stroke volume, systemic vascular resistance, arterial elastance and stroke work relationship.
LVSP indicates maximal LV pressure; LVEDP, LV end-diastolic pressure; EF, ejection fraction; dP/dt, maximum pressure development; ±dP/dt, minimum pressure development; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; Ea, Arterial elastance; and SW, stroke work. All values are expressed as mean±SEM.
IV. DISCUSSION
Despite the enhanced beneficial effects demonstrated for mesenchymal stem cell (MSC)-based therapy through modifications including pretreatment with growth factors and cytokines, preconditioning, and genetic modification, directly. The purpose of our study was to reveal the effects of periostin in cardiac protection and healing of infarcted hearts using MSCs as a periostin carrier. In fact, many studies showed that hypoxic surroundings had increased expression of periostin which interacts with the αvβ3, αvβ5-subunit of integrin and plays a crucial role in integrin-mediated cell adhesion and survival signaling. [23] [24] [25] Based on our observations, periostin protected against hypoxia-induced apoptosis of both MSCs and cardiomyocytes. In addition, transduction of the periostin gene enhanced phosphorylation of ERK and Akt, which play critical roles in regulation of integrin-mediated cell survival signals in hypoxic MSCs. 26, 27 We also observed an increase in the Bcl-2/Bax ratio and an inhibition of caspase-3 activation. Moreover, we observed increased expression of survival-related integrin molecules in cardiomyocytes co-cultured with p-MSCs or treated with CM containing periostin, suggesting that the anti-apoptotic effects of periostin are mediated by integrin-associated signal pathways. In fact, adhesion of cells to the ECM stimulates signal transduction cascades that are involved in proliferation, migration, differentiation, and even survival, [28] [29] [30] [31] which are all mediated by integrin molecules. 27, 32 In particular,
anchorage-dependent cells depend upon interactions between integrins and the extracellular matrix for survival. In addition, periostin enhances phosphorylation of protein kinase B (PKB/Akt), which plays a critical role in the regulation of adhesion-mediated cell survival signals. 13, 33, 34 Therefore, periostin functions as an important mediator in signal transduction from the ECM and thus regulates adhesion-dependent cell progression and the apoptotic pathway. According to our in vivo histological findings, transplantation of p-MSCs resulted in a further decrease in infarct size and a further improvement of LV function as compared to transplantation of unaltered MSCs. Moreover, the onset of microvessel density increase was closely correlated with repopulation of the infarcted area. Integrin-mediated adhesion is a prerequisite for cell survival and is also a key factor for the differentiation of MSCs.
V. CONCLUSION
As a novel anti-death strategy to improve stem cell survival/number in the infarcted heart, we genetically engineered MSCs to overexpress periostin to ultimately increase cell survival after implantation. Genetic modification of MSCs with periostin enhanced cell adhesion, survival rates, and cell adhesion-related signaling in vitro. P-MSCs further improved the cardiac function of infarcted myocardium compared to myocardium that had been transplanted with unaltered MSCs. These findings suggest that genetic modification of MSCs might be an effective therapeutic approach for treating infarcted myocardium.
